COMP <GO>
ELAN vs SMMT // EV/EBITDA & P/E VALUATION
Elanco Animal Health Incorporated (NYSE) VS. Summit Therapeutics Inc. (NASDAQ) • 15-METRIC TALLY: ELAN 7
— SMMT 4
■ METRIC PARITY
LAST: $24.10 (+4.51%) • MKT CAP: $11.52B
valuation
—
LAST: $14.80 (-7.67%) • MKT CAP: $12.82B
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ELAN VS. SMMT)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ELAN | SMMT | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 55.00% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -2.50% | -35.00% | +32.50 | ELAN | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 2.45% | -2.50% | +4.95 | ELAN | /fcf-yield <GO> |
| Operating Margin | -6.00% | -36.30% | +30.30 | ELAN | /operating-margins <GO> |
| Net Profit Margin | -4.90% | -29.80% | +24.90 | ELAN | /net-margins <GO> |
| Revenue Growth (YoY) | 6.20% | 11.00% | -4.80 | SMMT | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.24 | 26.00 | -24.76 | SMMT | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 5/9 | +2.00 | ELAN | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 51.9 | 50.5 | +1.40 | ELAN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.96 | 0.97 | -0.01 | SMMT | /macro-sensitivity <GO> |
| Forward P/E Multiple | 20.0x | 34.0x | -14.00 | ELAN | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $11.52B | $12.82B | -$1.30B | SMMT | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ELAN REV | SMMT REV | ELAN GROSS % | SMMT GROSS % | ELAN FCF | SMMT FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $4.71B | $3.57B | 55.0% | — | $284.0M | -$323.6M |
| FY 2024 | $4.44B | $632.8M | 54.9% | — | $394.0M | -$142.2M |
| FY 2023 | $4.42B | $1.71B | — | — | $72.2M | -$76.8M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ELAN // BETA 0.96
SMMT // BETA 0.97